You are here
ASTROCYTE PHARMACEUTICALS INC.
UEI: ZEP1G3FGYUP3
# of Employees: 2
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Astrocyte activation by small-molecule ADORA3 agonists: a novel therapy for Alzheimer's disease
Amount: $297,948.00PROJECT SUMMARY Alzheimerandapos s diseaseADis an area of significant unmet need that creates a national burden of$billion annuallyAD is the leading cause of dementiaaffectingof Americans over the age ...
STTRPhase I2018Department of Health and Human Services National Institutes of Health -
Preclinical development of AST-004 for astrocyte-mediated treatment of TBI.
Amount: $2,995,818.00PROJECT SUMMARY Traumatic brain injuriesTBIincluding concussionsare an area of significant unmet need with no approved therapeutics and a national burden of$billion annuallyTBI is the global leading c ...
SBIRPhase II2018Department of Health and Human Services National Institutes of Health -
ASTROCYTE ACTIVATION BY SMALL MOLECULE P2Y1 AGONISTS FOR TREATMENT OF TBI
Amount: $671,659.00DESCRIPTION provided by applicant Traumatic brain injuries TBI are an area of significant unmet need with no approved therapeutics and a national burden of $ billion annually Astrocyte Pharma ...
STTRPhase I2015Department of Health and Human Services National Institutes of Health
